Medical products distributor Henry Schein (NASDAQ:HSIC) inks an agreement with UK-based Radic8 to sell its air purifier devices in the U.S. and Canada. Financial terms are not disclosed.
The Radic8 VirusKiller air purifier is currently being marketed for emergency use in the U.S. during the COVID-19 pandemic.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.